Crescent Biopharma Inc. (CBIO)
NASDAQ: CBIO
· Real-Time Price · USD
13.76
-0.03 (-0.22%)
At close: Aug 18, 2025, 3:59 PM
14.06
2.18%
After-hours: Aug 18, 2025, 04:25 PM EDT
Crescent Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 28.28M | 22.97M | -1.19M | -44.24M | -47.55M | 6.55M | -8.24M | 11.88M | -8.47M | -80.03M | -87.93M | -86.51M | -77.31M | -74.63M |
Depreciation & Amortization | 2.5M | 1.97M | 426K | 14K | 54K | 120K | 230K | 335K | 380K | 358K | 290K | 220K | 177K | 158K |
Stock-Based Compensation | 1.18M | 769K | 424K | 654K | 780K | 1.04M | 1.34M | 1.77M | 2.26M | 2.89M | 3.4M | 3.64M | 4M | 3.85M |
Other Working Capital | 14.75M | 12.86M | 3.43M | -2.26M | -2.14M | -5.48M | -2.88M | -4.37M | -2.64M | 1.65M | -1.51M | -5.61M | -6.83M | -6M |
Other Non-Cash Items | -31.47M | -31.53M | -12.46M | 30.6M | 30.77M | -26.42M | -21.48M | -54.4M | -50.95M | 6.05M | 3.89M | -1.9M | -2.47M | -146K |
Deferred Income Tax | 354K | 354K | 466K | 56K | 56K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 13.92M | 12.18M | 8.31M | -523K | -1.55M | -8.56M | -4.95M | -6.35M | -741K | 5.13M | 483K | -5.54M | -6.47M | -3.99M |
Operating Cash Flow | -4.67M | -7.76M | -3.96M | -13.38M | -17.44M | -27.26M | -33.1M | -49.3M | -63.62M | -71.45M | -83.75M | -88.19M | -79.6M | -74.61M |
Capital Expenditures | -3.13M | -3.01M | -693K | n/a | n/a | n/a | n/a | -347K | -839K | -1.19M | -1.19M | -878K | -581K | -250K |
Cash Acquisitions | -1.05M | -1.05M | -50K | 1M | 1M | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 12.39M | 12.39M | 14.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.89M | -50.55M | -91.62M |
Sales Maturities Of Investments | -5M | -5M | 5M | 7.5M | 7.5M | 57.5M | 60.01M | 60.37M | 67.9M | 23.95M | 49.03M | 79.64M | 95.7M | 101.69M |
Other Investing Acitivies | -29.72M | -30.81M | -14.92M | -2.25M | -3.25M | -5.17M | -2.08M | 3.24M | 10.77M | 23.95M | 49.03M | 73.75M | 45.15M | 10.07M |
Investing Cash Flow | -26.51M | -27.48M | 3.41M | 6.26M | 5.26M | 53.33M | 55.43M | 58.24M | 65.28M | 23.11M | 48.19M | 72.87M | 44.57M | 9.82M |
Debt Repayment | 37.48M | 37.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | -4K | -4K | -79K | -75K |
Dividend Paid | -12.76M | -14.26M | -5M | -12.76M | -11.26M | -7.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 835K | 22K | 22K | 45.05M | 2K | 2K | 16K | -45.01M | 114K | 110K | 49.55M | 49.99M | 49.81M | 77.91M |
Financial Cash Flow | 42.7M | 39.88M | -4.65M | -12.72M | -56.27M | -52.77M | -44.99M | -45.01M | 114K | 110K | 49.55M | 49.55M | 49.38M | 77.47M |
Net Cash Flow | 12.59M | 4.66M | -6.1M | -20.86M | -68.47M | -26.72M | -22.68M | -36.07M | 1.77M | -48.23M | 13.99M | 34.23M | 14.35M | 12.68M |
Free Cash Flow | 6.73M | 3.76M | -4.66M | -13.38M | -17.44M | -27.26M | -33.1M | -49.64M | -64.46M | -72.64M | -84.94M | -89.07M | -80.18M | -74.86M |